Breathe Technologies earns Medical Design Excellence Award for NIOV System Breathe Technology, Inc. It is made to facilitate ambulation for adult sufferers with respiratory insufficiency. ‘Breathe is honored to have been selected as a Winner of a 2012 Medical Design Excellence Awards sildenafil-au.com/real-reviews.html . To be acknowledged by MDEA underscores the innovative and unique aspects of the Breathe NIOV System. We believe our technology has the potential to allow patients with respiratory insufficiency to see greater flexibility and participation in actions of everyday living,’ said Larry Mastrovich, Breathe Technology, CEO and President.
Females between ages 20-59, the childbearing years may be a vulnerable period for its development. Postpartum screening of risk factors for center and diabetes disease may offer an important opportunity for primary prevention. – Recent research suggest a stronger hyperlink between Metabolic Syndrome to diabetes than coronary heart disease. Another latest Kaiser Permanente research by Gunderson published in the American Journal of Obstetrics and Gynecology in August 2009 discovered that females with gestational diabetes are 2.5 times much more likely to develop Metabolic Syndrome after pregnancy.